SFB 432: Mechanismen der Tumorabwehr und ihre therapeutische Beeinflussung
Forschungsverbund / Johannes Gutenberg-Universität Mainz
Erlach, KC; Bohm, V; Knabe, M et al.
Activation of hepatic natural killer cells and control of liver-adapted lymphoma in the murine model of cytomegalovirus infection.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 167-78
Distler, E; Wolfel, C; Kohler, S et al.
Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.Exp Hematol. Bd. 36. H. 4. 2008 S. 451-63
Holtappels, R; Bohm, V; Podlech, J et al.
CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 125-34
Sahin, U; Koslowski, M; Dhaene, K et al.
Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development.Clin Cancer Res. Bd. 14. H. 23. 2008 S. 7624-34
Wolfel, C; Lennerz, V; Lindemann, E et al.
Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation.Cancer Immunol Immunother. Bd. 57. H. 6. 2008 S. 849-57
Cicin-Sain, L; Ruzsics, Z; Podlech, J et al.
Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene.J Virol. Bd. 82. H. 5. 2008 S. 2056-64
Bohm, V; Podlech, J; Thomas, D et al.
Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 135-44
Tschiedel, S; Gentilini, C; Lange, T et al.
Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia.Leukemia. Bd. 22. H. 8. 2008 S. 1542-50
Javorovic, M; Wilde, S; Zobywalski, A et al.
Inhibitory effect of RNA pool complexity on stimulatory capacity of RNA-pulsed dendritic cells.J Immunother. Bd. 31. H. 1. 2008 S. 52-62
Wirtz, N; Schader, SI; Holtappels, R et al.
Polyclonal cytomegalovirus-specific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 151-8